Assessing cognition in people with severe mental disorders in low- and middle-income countries: a systematic review of assessment measures
Open Access
- 18 June 2021
- journal article
- review article
- Published by Springer Nature in Social Psychiatry and Psychiatric Epidemiology
- Vol. 57 (3) , 435-460
Abstract
Background: Cognitive difficulties are common in people with severe mental disorders (SMDs) and various measures of cognition are of proven validity. However, there is a lack of systematic evidence regarding the psychometric properties of these measures in low- and middle-income countries (LMICs). Objective: To systematically review the psychometric properties of cognitive measures validated in people with SMDs in LMICs. Methods: We conducted a systematic review of the literature by searching from four electronic databases. Two authors independently screened studies for their eligibility. Measurement properties of measures in all included studies were extracted. All eligible measures were assessed against criteria set for clinical and research recommendations. Results are summarized narratively and measures were grouped by measurement type and population. Results: We identified 23 unique measures from 28 studies. None of these was from low-income settings. Seventeen of the measures were performance-based. The majority (n = 16/23) of the measures were validated in people with schizophrenia. The most commonly reported measurement properties were: known group, convergent, and divergent validity (n = 25/28). For most psychometric property, studies of methodological qualities were found to be doubtful. Among measures evaluated in people with schizophrenia, Brief Assessment of Cognition in Schizophrenia, Cognitive Assessment Interview, MATRICS Consensus Cognitive Battery, and CogState Schizophrenia Battery were with the highest scores for clinical and research recommendation. Conclusions: Studies included in our review provide only limited quality evidence and future studies should consider adapting and validating measures using stronger designs and methods. Nonetheless, validated assessments of cognition could help in the management and allocating therapy in people with SMDs in LMICs.Keywords
Funding Information
- African Academy of Sciences (AAS)’s Alliance for Accelerating Excellence in Science in Africa (DELTAS Africa Initiative [DEL-15-01])
This publication has 72 references indexed in Scilit:
- Reliability and Validity of the CogState Battery Chinese Language Version in SchizophreniaPLOS ONE, 2013
- Cognitive impairment in euthymic major depressive disorder: a meta-analysisPsychological Medicine, 2012
- Cognitive deficits in schizophrenia: an updated metanalysis of the scientific evidenceBMC Psychiatry, 2012
- Assessment of anxiety in older adults: A systematic review of commonly used measuresAging & Mental Health, 2011
- Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklistQuality of Life Research, 2011
- Clinical Validity of the Repeatable Battery for the Assessment of Neuropsychological Status among Patients with Schizophrenia in the Republic of ArmeniaArchives of Clinical Neuropsychology, 2010
- The Self-Assessment Scale of Cognitive Complaints in Schizophrenia: A validation study in Tunisian populationBMC Psychiatry, 2009
- Cognitive Impairment in Affective Psychoses: A Meta-analysisSchizophrenia Bulletin, 2009
- The MATRICS Consensus Cognitive Battery, Part 1: Test Selection, Reliability, and ValidityAmerican Journal of Psychiatry, 2008
- Influence of language background on tests of cognitive abilities: Australian dataAustralian Psychologist, 2006